Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20052 | 26190322 | Hepatol Res | Chronic hepatitis without hepatic steatosis caused by citrin deficiency in a child. | 2015 | Details |
| A20053 | 26190035 | Hepatol Res | Amelioration of free fatty acid-induced fatty liver by quercetin-3-O-β-D-glucuronide through modulation of peroxisome proliferator-activated receptor-alpha/sterol regulatory element-binding protein-1c signaling. | 2015 | Details |
| A20054 | 26189985 | Clin Res Hepatol Gastroenterol | Synergy between NAFLD and AFLD and potential biomarkers. | 2015 | Details |
| A20055 | 26189925 | Hepatology | Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis. | 2015 | Details |
| A20056 | 26187937 | JPEN J Parenter Enteral Nutr | Clinically Relevant Mechanisms of Lipid Synthesis, Transport, and Storage. | 2015 | Details |
| A20058 | 26187450 | Toxicol Sci | Low-Dose Cadmium Causes Metabolic and Genetic Dysregulation Associated With Fatty Liver Disease in Mice. | 2015 | Details |
| A20059 | 26187275 | Toxicol In Vitro | The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH. | 2015 | Details |
| A20060 | 26186426 | J Med Food | Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content. | 2015 | Details |
| A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
| A20062 | 26185381 | World J Gastroenterol | Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. | 2015 | Details |
| A20063 | 26185377 | World J Gastroenterol | Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. | 2015 | Details |
| A20064 | 26183212 | Dis Model Mech | Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis. | 2015 | Details |
| A20065 | 26182253 | Dtsch Med Wochenschr | [Non-alcoholic fatty liver disease (NAFLD)]. | 2015 | Details |
| A20066 | 26179949 | Sci Rep | Oral administration of the Aureobasidium pullulans-derived β-glucan effectively prevents the development of high fat diet-induced fatty liver in mice. | 2015 | Details |
| A20068 | 26179110 | Hepatol Res | Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis. | 2015 | Details |
| A20069 | 26178698 | Hepatology | CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis. | 2015 | Details |
| A20070 | 26176710 | Liver Int | The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. | 2015 | Details |
| A20071 | 26176317 | J Agric Food Chem | Fermented Rhus verniciflua Stokes Extract Exerts an Antihepatic Lipogenic Effect in Oleic-Acid-Induced HepG2 Cells via Upregulation of AMP-Activated Protein Kinase. | 2015 | Details |
| A20072 | 26175982 | Iran J Public Health | Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran. | 2014 | Details |
| A20073 | 26174847 | Sleep Breath | Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults. | 2015 | Details |
| A20074 | 26174761 | Arab J Gastroenterol | Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit? | 2015 | Details |
| A20075 | 26173506 | Dig Dis Sci | Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease. | 2015 | Details |
| A20076 | 26173075 | Menopause | Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. | 2016 | Details |
| A20077 | 26172853 | Biochim Biophys Acta | Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression. | 2015 | Details |
| A20078 | 26170532 | Mediators Inflamm | LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20082 | 26169265 | Cardiovasc Diabetol | Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. | 2015 | Details |
| A20083 | 26168700 | J Nutr Biochem | Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. | 2015 | Details |
| A20085 | 26167414 | Adipocyte | The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. | 2015 | Details |
| A20086 | 26167390 | J Clin Imaging Sci | The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. | 2015 | Details |
| A20087 | 26167252 | World J Hepatol | Non-alcohol fatty liver disease in Asia: Prevention and planning. | 2015 | Details |
| A20088 | 26167244 | World J Hepatol | Is there a role for adaptive immunity in nonalcoholic steatohepatitis? | 2015 | Details |
| A20089 | 26167086 | World J Gastroenterol | Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. | 2015 | Details |
| A20090 | 26166101 | Medicine (Baltimore) | Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20091 | 26160475 | Clin Res Hepatol Gastroenterol | Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review. | 2015 | Details |
| A20092 | 26160474 | Clin Res Hepatol Gastroenterol | Novel therapeutic targets for steatohepatitis. | 2015 | Details |
| A20093 | 26159457 | Sci Rep | Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice. | 2015 | Details |
| A20094 | 26159280 | Dig Dis | Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. | 2015 | Details |
| A20095 | 26157039 | Ultrason Imaging | Doppler Tissue Evaluation of Atrial Conduction Properties in Patients With Non-alcoholic Fatty-liver Disease. | 2015 | Details |
| A20096 | 26156527 | Diabetes Care | Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes. | 2015 | Details |
| A20097 | 26156419 | Mini Rev Med Chem | The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20098 | 26156412 | J Am Coll Nutr | Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. | 2015 | Details |
| A20099 | 26155623 | Ter Arkh | [Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20100 | 26155043 | J Clin Exp Hepatol | The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20101 | 26155039 | J Clin Exp Hepatol | Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors. | 2015 | Details |
| A20102 | 26154274 | Menopause | Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. | 2015 | Details |
| A20104 | 28210697 | Cell Mol Gastroenterol Hepatol | Angiogenesis and Fibrogenesis in Chronic Liver Diseases. | 2015 | Details |
| A20105 | 26151688 | Acta Gastroenterol Belg | Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20106 | 26151226 | Clin Biochem | Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. | 2015 | Details |
| A20107 | 26151056 | Hepatobiliary Surg Nutr | Carotenoids and non-alcoholic fatty liver disease. | 2015 | Details |
| A20108 | 26151054 | Hepatobiliary Surg Nutr | Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD). | 2015 | Details |
| A20110 | 26148245 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: a potential consequence of tumor necrosis factor-inhibitor therapy. | 2015 | Details |
| A20111 | 26148225 | Liver Int | I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. | 2015 | Details |
| A20112 | 26147768 | Hepatol Res | Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus. | 2015 | Details |
| A20113 | 26147696 | Hepatol Res | Glucagon-like peptide-1 preserves non-alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stress-associated pathway. | 2015 | Details |
| A20114 | 26147308 | Clin Transplant | Non-alcoholic fatty liver disease following liver transplantation: a clinical review. | 2015 | Details |
| A20115 | 26147081 | Nature | The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. | 2015 | Details |
| A20116 | 26146507 | Evid Based Complement Alternat Med | Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20117 | 26144271 | Metabolism | Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study. | 2015 | Details |
| A20118 | 26143342 | Dig Dis Sci | Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20119 | 26140093 | World J Hepatol | Non-alcoholic fatty liver disease and beneficial effects of dietary supplements. | 2015 | Details |
| A20120 | 26140091 | World J Hepatol | Hepatocellular carcinoma in Asia: Prevention strategy and planning. | 2015 | Details |
| A20121 | 26140087 | World J Hepatol | Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. | 2015 | Details |
| A20122 | 26140084 | World J Hepatol | Systematic review: Preventive and therapeutic applications of metformin in liver disease. | 2015 | Details |
| A20123 | 26140000 | World J Gastroenterol | Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology. | 2015 | Details |
| A20124 | 26139990 | World J Gastroenterol | Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance. | 2015 | Details |
| A20125 | 26139988 | World J Gastroenterol | Liver fibrosis markers of nonalcoholic steatohepatitis. | 2015 | Details |
| A20127 | 26138749 | Expert Rev Gastroenterol Hepatol | In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications? | 2015 | Details |
| A20128 | 26138724 | Obes Facts | The Association between Sleep Duration and Non-Alcoholic Fatty Liver Disease among Japanese Men and Women. | 2015 | Details |
| A20129 | 26138654 | Dig Dis Sci | Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20130 | 26138508 | BMC Res Notes | Prevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors. | 2015 | Details |
| A20131 | 26137185 | Oxid Med Cell Longev | Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β. | 2015 | Details |
| A20132 | 26136587 | J Nutr | PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity. | 2015 | Details |
| A20133 | 26134926 | Expert Opin Drug Saf | Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect? | 2015 | Details |
| A20134 | 26134756 | Pharm Biol | Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. | 2015 | Details |
| A20135 | 26133980 | Liver Int | Probe-based confocal laser endomicroscopy quantitative morphometric markers associated with portal hypertension in duodenal mucosa. | 2015 | Details |
| A20136 | 26133820 | Zhonghua Gan Zang Bing Za Zhi | [Effects of telmisartan on resistin expression in a rat model of nonalcoholic steatohepatitis and insulin resistance]. | 2015 | Details |
| A20137 | 26133486 | Int J Mol Med | Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model. | 2015 | Details |
| A20138 | 26133299 | Eur J Nutr | Bee's honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein-NLRP3 inflammasome pathway. | 2015 | Details |
| A20139 | 26133108 | Clin Transl Gastroenterol | Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation. | 2015 | Details |
| A20140 | 26133037 | J Med Food | Beneficial Effects of Red Yeast Rice on High-Fat Diet-Induced Obesity, Hyperlipidemia, and Fatty Liver in Mice. | 2015 | Details |
| A20141 | 26132376 | Pediatr Obes | Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS). | 2015 | Details |
| A20142 | 26131717 | PLoS One | Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis. | 2015 | Details |
| A20144 | 26126685 | Am J Physiol Endocrinol Metab | Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line. | 2015 | Details |
| A20145 | 26125952 | PLoS One | Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. | 2015 | Details |
| A20146 | 26124760 | Front Immunol | Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies. | 2015 | Details |
| A20147 | 26124313 | J Clin Pathol | Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation. | 2015 | Details |
| A20148 | 26123841 | Liver Int | Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. | 2015 | Details |
| A20152 | 26121037 | PLoS One | Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis. | 2015 | Details |
| A20153 | 26120587 | Biomed Res Int | Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals. | 2015 | Details |
| A20154 | 26120584 | Biomed Res Int | The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism. | 2015 | Details |
| A20155 | 26119353 | Aliment Pharmacol Ther | Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20156 | 26118770 | Recent Pat Food Nutr Agric | Soybean and Processed Soy Foods Ingredients, and Their Role in Cardiometabolic Risk Prevention. | 2015 | Details |
| A20157 | 26117210 | Vascul Pharmacol | Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome. | 2015 | Details |
| A20160 | 26116591 | Ann Clin Lab Sci | Neutrophil-Lymphocyte Ratio (NLR) Could Be Better Predictor than C-reactive Protein (CRP) for Liver Fibrosis in Non-alcoholic Steatohepatitis(NASH). | 2015 | Details |
| A20161 | 26116463 | Sleep Med | Obstructive sleep apnea is associated with liver disease: a population-based cohort study. | 2015 | Details |
| A20162 | 26116377 | Arch Biochem Biophys | Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice. | 2015 | Details |
| A20163 | 26116119 | EJNMMI Res | Potential of (99m)Tc-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice. | 2014 | Details |
| A20164 | 26114995 | Liver Int | Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. | 2015 | Details |
| A20165 | 26114603 | J Magn Reson Imaging | In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence. | 2015 | Details |
| A20166 | 26114447 | Food Funct | Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway. | 2015 | Details |